Report Detail
Global Cardiovascular and Cerebrovascular API Supply, Demand and Key Producers, 2026-2032
- RnM4666885 |
- 22 January, 2026 |
- Global |
- 132 Pages |
- GIR |
- Chemical & Material
The global Cardiovascular and Cerebrovascular API market size is expected to reach $ 4088 million by 2032, rising at a market growth of 2.6% CAGR during the forecast period (2026-2032).
Cardiovascular disease (CVD) is the leading cause of death in the world. The number of people who die of cardiovascular disease is the largest every year. Cardiovascular drugs are used to treat cardiovascular diseases, including antihypertensive drugs, anti angina drugs, anti heart failure drugs, antiarrhythmic drugs, lipid-lowering drugs and so on. The main raw materials of cardio cerebrovascular drugs include sartan, statins, pril and so on.
China is the main production area of cardiovascular and cerebrovascular raw materials, with a market share of more than 65%, followed by India and Europe.
The key manufacturers are Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, MSN Life Sciences etc. Zhejiang Huahai Pharmaceutical Co., Ltd. is the largest producer of cardiovascular and cerebrovascular raw materials in China region market and global market, accounting for more than 10%.
This report studies the global Cardiovascular and Cerebrovascular API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiovascular and Cerebrovascular API and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiovascular and Cerebrovascular API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cardiovascular and Cerebrovascular API total production and demand, 2021-2032, (MT)
Global Cardiovascular and Cerebrovascular API total production value, 2021-2032, (USD Million)
Global Cardiovascular and Cerebrovascular API production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Cardiovascular and Cerebrovascular API consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Cardiovascular and Cerebrovascular API domestic production, consumption, key domestic manufacturers and share
Global Cardiovascular and Cerebrovascular API production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Cardiovascular and Cerebrovascular API production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Cardiovascular and Cerebrovascular API production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Cardiovascular and Cerebrovascular API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zhuhai Rundu Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Lepu Pharmaceutical, Zhejiang Jiangbei Pharmaceutical, DR.Reddy, Glenmerk, Cipla, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiovascular and Cerebrovascular API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cardiovascular and Cerebrovascular API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Cardiovascular and Cerebrovascular API Market, Segmentation by Type:
Sartans Cardiovascular and Cerebrovascular API
Statins Cardiovascular and Cerebrovascular API
Puri Cardiovascular and Cerebrovascular API
Global Cardiovascular and Cerebrovascular API Market, Segmentation by Application:
Oral Drugs
Injection Drugs
Companies Profiled:
Zhuhai Rundu Pharmaceutical
Ningbo Menovo Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Lepu Pharmaceutical
Zhejiang Jiangbei Pharmaceutical
DR.Reddy
Glenmerk
Cipla
MSN Life Sciences
Key Questions Answered:
1. How big is the global Cardiovascular and Cerebrovascular API market?
2. What is the demand of the global Cardiovascular and Cerebrovascular API market?
3. What is the year over year growth of the global Cardiovascular and Cerebrovascular API market?
4. What is the production and production value of the global Cardiovascular and Cerebrovascular API market?
5. Who are the key producers in the global Cardiovascular and Cerebrovascular API market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Cardiovascular and Cerebrovascular API Introduction
- 1.2 World Cardiovascular and Cerebrovascular API Supply & Forecast
- 1.2.1 World Cardiovascular and Cerebrovascular API Production Value (2021 & 2025 & 2032)
- 1.2.2 World Cardiovascular and Cerebrovascular API Production (2021-2032)
- 1.2.3 World Cardiovascular and Cerebrovascular API Pricing Trends (2021-2032)
- 1.3 World Cardiovascular and Cerebrovascular API Production by Region (Based on Production Site)
- 1.3.1 World Cardiovascular and Cerebrovascular API Production Value by Region (2021-2032)
- 1.3.2 World Cardiovascular and Cerebrovascular API Production by Region (2021-2032)
- 1.3.3 World Cardiovascular and Cerebrovascular API Average Price by Region (2021-2032)
- 1.3.4 North America Cardiovascular and Cerebrovascular API Production (2021-2032)
- 1.3.5 Europe Cardiovascular and Cerebrovascular API Production (2021-2032)
- 1.3.6 China Cardiovascular and Cerebrovascular API Production (2021-2032)
- 1.3.7 India Cardiovascular and Cerebrovascular API Production (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Cardiovascular and Cerebrovascular API Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Cardiovascular and Cerebrovascular API Major Market Trends
2 Demand Summary
- 2.1 World Cardiovascular and Cerebrovascular API Demand (2021-2032)
- 2.2 World Cardiovascular and Cerebrovascular API Consumption by Region
- 2.2.1 World Cardiovascular and Cerebrovascular API Consumption by Region (2021-2026)
- 2.2.2 World Cardiovascular and Cerebrovascular API Consumption Forecast by Region (2027-2032)
- 2.3 United States Cardiovascular and Cerebrovascular API Consumption (2021-2032)
- 2.4 China Cardiovascular and Cerebrovascular API Consumption (2021-2032)
- 2.5 Europe Cardiovascular and Cerebrovascular API Consumption (2021-2032)
- 2.6 Japan Cardiovascular and Cerebrovascular API Consumption (2021-2032)
- 2.7 South Korea Cardiovascular and Cerebrovascular API Consumption (2021-2032)
- 2.8 ASEAN Cardiovascular and Cerebrovascular API Consumption (2021-2032)
- 2.9 India Cardiovascular and Cerebrovascular API Consumption (2021-2032)
3 World Manufacturers Competitive Analysis
- 3.1 World Cardiovascular and Cerebrovascular API Production Value by Manufacturer (2021-2026)
- 3.2 World Cardiovascular and Cerebrovascular API Production by Manufacturer (2021-2026)
- 3.3 World Cardiovascular and Cerebrovascular API Average Price by Manufacturer (2021-2026)
- 3.4 Cardiovascular and Cerebrovascular API Company Evaluation Quadrant
- 3.5 Industry Rank and Concentration Rate (CR)
- 3.5.1 Global Cardiovascular and Cerebrovascular API Industry Rank of Major Manufacturers
- 3.5.2 Global Concentration Ratios (CR4) for Cardiovascular and Cerebrovascular API in 2025
- 3.5.3 Global Concentration Ratios (CR8) for Cardiovascular and Cerebrovascular API in 2025
- 3.6 Cardiovascular and Cerebrovascular API Market: Overall Company Footprint Analysis
- 3.6.1 Cardiovascular and Cerebrovascular API Market: Region Footprint
- 3.6.2 Cardiovascular and Cerebrovascular API Market: Company Product Type Footprint
- 3.6.3 Cardiovascular and Cerebrovascular API Market: Company Product Application Footprint
- 3.7 Competitive Environment
- 3.7.1 Historical Structure of the Industry
- 3.7.2 Barriers of Market Entry
- 3.7.3 Factors of Competition
- 3.8 New Entrant and Capacity Expansion Plans
- 3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
- 4.1 United States VS China: Cardiovascular and Cerebrovascular API Production Value Comparison
- 4.1.1 United States VS China: Cardiovascular and Cerebrovascular API Production Value Comparison (2021 & 2025 & 2032)
- 4.1.2 United States VS China: Cardiovascular and Cerebrovascular API Production Value Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States VS China: Cardiovascular and Cerebrovascular API Production Comparison
- 4.2.1 United States VS China: Cardiovascular and Cerebrovascular API Production Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Cardiovascular and Cerebrovascular API Production Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States VS China: Cardiovascular and Cerebrovascular API Consumption Comparison
- 4.3.1 United States VS China: Cardiovascular and Cerebrovascular API Consumption Comparison (2021 & 2025 & 2032)
- 4.3.2 United States VS China: Cardiovascular and Cerebrovascular API Consumption Market Share Comparison (2021 & 2025 & 2032)
- 4.4 United States Based Cardiovascular and Cerebrovascular API Manufacturers and Market Share, 2021-2026
- 4.4.1 United States Based Cardiovascular and Cerebrovascular API Manufacturers, Headquarters and Production Site (States, Country)
- 4.4.2 United States Based Manufacturers Cardiovascular and Cerebrovascular API Production Value (2021-2026)
- 4.4.3 United States Based Manufacturers Cardiovascular and Cerebrovascular API Production (2021-2026)
- 4.5 China Based Cardiovascular and Cerebrovascular API Manufacturers and Market Share
- 4.5.1 China Based Cardiovascular and Cerebrovascular API Manufacturers, Headquarters and Production Site (Province, Country)
- 4.5.2 China Based Manufacturers Cardiovascular and Cerebrovascular API Production Value (2021-2026)
- 4.5.3 China Based Manufacturers Cardiovascular and Cerebrovascular API Production (2021-2026)
- 4.6 Rest of World Based Cardiovascular and Cerebrovascular API Manufacturers and Market Share, 2021-2026
- 4.6.1 Rest of World Based Cardiovascular and Cerebrovascular API Manufacturers, Headquarters and Production Site (State, Country)
- 4.6.2 Rest of World Based Manufacturers Cardiovascular and Cerebrovascular API Production Value (2021-2026)
- 4.6.3 Rest of World Based Manufacturers Cardiovascular and Cerebrovascular API Production (2021-2026)
5 Market Analysis by Type
- 5.1 World Cardiovascular and Cerebrovascular API Market Size Overview by Type: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Type
- 5.2.1 Sartans Cardiovascular and Cerebrovascular API
- 5.2.2 Statins Cardiovascular and Cerebrovascular API
- 5.2.3 Puri Cardiovascular and Cerebrovascular API
- 5.3 Market Segment by Type
- 5.3.1 World Cardiovascular and Cerebrovascular API Production by Type (2021-2032)
- 5.3.2 World Cardiovascular and Cerebrovascular API Production Value by Type (2021-2032)
- 5.3.3 World Cardiovascular and Cerebrovascular API Average Price by Type (2021-2032)
6 Market Analysis by Application
- 6.1 World Cardiovascular and Cerebrovascular API Market Size Overview by Application: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Application
- 6.2.1 Oral Drugs
- 6.2.2 Injection Drugs
- 6.3 Market Segment by Application
- 6.3.1 World Cardiovascular and Cerebrovascular API Production by Application (2021-2032)
- 6.3.2 World Cardiovascular and Cerebrovascular API Production Value by Application (2021-2032)
- 6.3.3 World Cardiovascular and Cerebrovascular API Average Price by Application (2021-2032)
7 Company Profiles
- 7.1 Zhuhai Rundu Pharmaceutical
- 7.1.1 Zhuhai Rundu Pharmaceutical Details
- 7.1.2 Zhuhai Rundu Pharmaceutical Major Business
- 7.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 7.1.4 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.1.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
- 7.1.6 Zhuhai Rundu Pharmaceutical Competitive Strengths & Weaknesses
- 7.2 Ningbo Menovo Pharmaceutical
- 7.2.1 Ningbo Menovo Pharmaceutical Details
- 7.2.2 Ningbo Menovo Pharmaceutical Major Business
- 7.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 7.2.4 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.2.5 Ningbo Menovo Pharmaceutical Recent Developments/Updates
- 7.2.6 Ningbo Menovo Pharmaceutical Competitive Strengths & Weaknesses
- 7.3 Zhejiang Huahai Pharmaceutical
- 7.3.1 Zhejiang Huahai Pharmaceutical Details
- 7.3.2 Zhejiang Huahai Pharmaceutical Major Business
- 7.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 7.3.4 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.3.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
- 7.3.6 Zhejiang Huahai Pharmaceutical Competitive Strengths & Weaknesses
- 7.4 Zhejiang Tianyu Pharmaceutical
- 7.4.1 Zhejiang Tianyu Pharmaceutical Details
- 7.4.2 Zhejiang Tianyu Pharmaceutical Major Business
- 7.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 7.4.4 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.4.5 Zhejiang Tianyu Pharmaceutical Recent Developments/Updates
- 7.4.6 Zhejiang Tianyu Pharmaceutical Competitive Strengths & Weaknesses
- 7.5 Zhejiang Hisun Pharmaceutical
- 7.5.1 Zhejiang Hisun Pharmaceutical Details
- 7.5.2 Zhejiang Hisun Pharmaceutical Major Business
- 7.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 7.5.4 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.5.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
- 7.5.6 Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses
- 7.6 Zhejiang Lepu Pharmaceutical
- 7.6.1 Zhejiang Lepu Pharmaceutical Details
- 7.6.2 Zhejiang Lepu Pharmaceutical Major Business
- 7.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 7.6.4 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.6.5 Zhejiang Lepu Pharmaceutical Recent Developments/Updates
- 7.6.6 Zhejiang Lepu Pharmaceutical Competitive Strengths & Weaknesses
- 7.7 Zhejiang Jiangbei Pharmaceutical
- 7.7.1 Zhejiang Jiangbei Pharmaceutical Details
- 7.7.2 Zhejiang Jiangbei Pharmaceutical Major Business
- 7.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product and Services
- 7.7.4 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.7.5 Zhejiang Jiangbei Pharmaceutical Recent Developments/Updates
- 7.7.6 Zhejiang Jiangbei Pharmaceutical Competitive Strengths & Weaknesses
- 7.8 DR.Reddy
- 7.8.1 DR.Reddy Details
- 7.8.2 DR.Reddy Major Business
- 7.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Product and Services
- 7.8.4 DR.Reddy Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.8.5 DR.Reddy Recent Developments/Updates
- 7.8.6 DR.Reddy Competitive Strengths & Weaknesses
- 7.9 Glenmerk
- 7.9.1 Glenmerk Details
- 7.9.2 Glenmerk Major Business
- 7.9.3 Glenmerk Cardiovascular and Cerebrovascular API Product and Services
- 7.9.4 Glenmerk Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.9.5 Glenmerk Recent Developments/Updates
- 7.9.6 Glenmerk Competitive Strengths & Weaknesses
- 7.10 Cipla
- 7.10.1 Cipla Details
- 7.10.2 Cipla Major Business
- 7.10.3 Cipla Cardiovascular and Cerebrovascular API Product and Services
- 7.10.4 Cipla Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.10.5 Cipla Recent Developments/Updates
- 7.10.6 Cipla Competitive Strengths & Weaknesses
- 7.11 MSN Life Sciences
- 7.11.1 MSN Life Sciences Details
- 7.11.2 MSN Life Sciences Major Business
- 7.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Product and Services
- 7.11.4 MSN Life Sciences Cardiovascular and Cerebrovascular API Production, Price, Value, Gross Margin and Market Share (2021-2026)
- 7.11.5 MSN Life Sciences Recent Developments/Updates
- 7.11.6 MSN Life Sciences Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Cardiovascular and Cerebrovascular API Industry Chain
- 8.2 Cardiovascular and Cerebrovascular API Upstream Analysis
- 8.2.1 Cardiovascular and Cerebrovascular API Core Raw Materials
- 8.2.2 Main Manufacturers of Cardiovascular and Cerebrovascular API Core Raw Materials
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis
- 8.5 Cardiovascular and Cerebrovascular API Production Mode
- 8.6 Cardiovascular and Cerebrovascular API Procurement Model
- 8.7 Cardiovascular and Cerebrovascular API Industry Sales Model and Sales Channels
- 8.7.1 Cardiovascular and Cerebrovascular API Sales Model
- 8.7.2 Cardiovascular and Cerebrovascular API Typical Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cardiovascular and Cerebrovascular API. Industry analysis & Market Report on Cardiovascular and Cerebrovascular API is a syndicated market report, published as Global Cardiovascular and Cerebrovascular API Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Cardiovascular and Cerebrovascular API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
